Combination of the protein structure for molecular docking was performed with UCSF ChimeraX, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from National Institutes of Health R01-GM129325 and the Office of Cyber Infrastructure and Computational Biology, National Institute of Allergy and Infectious Diseases
and an inhibitor of the lipid transporter ABCA1 (ATP-binding cassette transporter A1), which transfers lipids to ApoE
This products certificate of analysis is available on request
Store this medicine as directed on the prescription label
by the National Radio Astronomy Observatory (NRAO), managed by Associated Universities, Inc
Using an insulin syringe, draw the calculated volume of bacteriostatic water (typically 2 mL)